Literature DB >> 19003640

Neutrophils, but not lymphocytes or monocytes, infiltrate maternal systemic vasculature in women with preeclampsia.

Kristen A Cadden1, Scott W Walsh.   

Abstract

OBJECTIVE: Leukocytes are activated in women with preeclampsia, but the class of leukocytes that infiltrates the maternal vasculature and, therefore, is most likely to cause vascular dysfunction is not known.
METHODS: Subcutaneous fat biopsies were obtained at Cesarean section or abdominal surgery from 7 normal non-pregnant women, 7 women with normal pregnancies, and 7 women with preeclampsia. Tissues were immunohistochemically stained for CD14, a monocyte/macrophage antigen, CD99, a lymphocyte antigen, and CD66b, a neutrophil antigen.
RESULTS: CD14 stained cells were found infiltrated into fat tissue but were not present in vessels for any of the groups. CD99-stained cells were present in approximately 20% to 30% of vessels with no difference among groups. CD66b-stained cells were present in all groups with a significantly greater percentage of vessels stained for preeclamptic than normal pregnant or normal non-pregnant women (70 +/- 6 vs. 43 +/- 9 vs. 21 +/- 5%, respectively, p < 0.01). CD66b cells were the most abundant cell type that infiltrated vessels of preeclamptic women.
CONCLUSIONS: 1) A significantly greater number of neutrophils adhered to endothelium and infiltrated into the intimal space in the maternal systemic vasculature of preeclamptic women than in that of normal pregnant women or normal non-pregnant women; 2) No significant difference in lymphocyte infiltration was observed among the patient groups, and lymphocytes were present in much lower numbers than-neutrophils; 3) Monocytes/macrophages were found in fat tissue but not in vessels. We speculate that neutrophils are the class of leukocytes that cause the majority of vascular cell dysfunction in women with preeclampsia.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19003640      PMCID: PMC2593156          DOI: 10.1080/10641950801958067

Source DB:  PubMed          Journal:  Hypertens Pregnancy        ISSN: 1064-1955            Impact factor:   2.108


  23 in total

1.  Cytokine-activated human vascular smooth muscle delays apoptosis of neutrophils: relevance of interactions between cyclo-oxygenase-2 and colony-stimulating factors.

Authors:  S J Stanford; J R Pepper; A Burke-Gaffney; J A Mitchell
Journal:  FASEB J       Date:  2001-08       Impact factor: 5.191

2.  Phenotypic and metabolic characteristics of monocytes and granulocytes in preeclampsia.

Authors:  M T Gervasi; T Chaiworapongsa; P Pacora; N Naccasha; B H Yoon; E Maymon; R Romero
Journal:  Am J Obstet Gynecol       Date:  2001-10       Impact factor: 8.661

3.  Neutrophils from pregnant women produce thromboxane and tumor necrosis factor-alpha in response to linoleic acid and oxidative stress.

Authors:  John E Vaughan; Scott W Walsh
Journal:  Am J Obstet Gynecol       Date:  2005-09       Impact factor: 8.661

4.  Evidence for peroxynitrite formation in the vasculature of women with preeclampsia.

Authors:  A M Roggensack; Y Zhang; S T Davidge
Journal:  Hypertension       Date:  1999-01       Impact factor: 10.190

5.  Placental isoprostane is significantly increased in preeclampsia.

Authors:  S W Walsh; J E Vaughan; Y Wang; L J Roberts
Journal:  FASEB J       Date:  2000-07       Impact factor: 5.191

6.  Thromboxane mediates neutrophil superoxide production in pregnancy.

Authors:  John E Vaughan; Scott W Walsh; George D Ford
Journal:  Am J Obstet Gynecol       Date:  2006-04-27       Impact factor: 8.661

7.  The superoxide generation of neutrophils in normal and preeclamptic pregnancies.

Authors:  K Tsukimori; H Maeda; K Ishida; H Nagata; T Koyanagi; H Nakano
Journal:  Obstet Gynecol       Date:  1993-04       Impact factor: 7.661

8.  Concentrations of serum granulocyte-colony-stimulating factor in normal pregnancy and preeclampsia.

Authors:  K Matsubara; H Ochi; H Kitagawa; K Yamanaka; Y Kusanagi; M Ito
Journal:  Hypertens Pregnancy       Date:  1999       Impact factor: 2.108

9.  Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis.

Authors:  G P Sacks; K Studena; K Sargent; C W Redman
Journal:  Am J Obstet Gynecol       Date:  1998-07       Impact factor: 8.661

Review 10.  Maternal-placental interactions of oxidative stress and antioxidants in preeclampsia.

Authors:  S W Walsh
Journal:  Semin Reprod Endocrinol       Date:  1998
View more
  23 in total

1.  Neutrophil release of myeloperoxidase in systemic vasculature of obese women may put them at risk for preeclampsia.

Authors:  Juhi Shukla; Scott W Walsh
Journal:  Reprod Sci       Date:  2014-11-12       Impact factor: 3.060

2.  Mechanisms of enhanced vascular reactivity in preeclampsia.

Authors:  Nikita Mishra; William H Nugent; Sunila Mahavadi; Scott W Walsh
Journal:  Hypertension       Date:  2011-09-26       Impact factor: 10.190

3.  Matrix Metalloproteinase 1 Causes Vasoconstriction and Enhances Vessel Reactivity to Angiotensin II via Protease-Activated Receptor 1.

Authors:  William H Nugent; Nikita Mishra; Jerome F Strauss; Scott W Walsh
Journal:  Reprod Sci       Date:  2015-10-04       Impact factor: 3.060

4.  Increased expression of matrix metalloproteinase-1 in systemic vessels of preeclamptic women: a critical mediator of vascular dysfunction.

Authors:  Guadalupe Estrada-Gutierrez; Renato E Cappello; Nikita Mishra; Roberto Romero; Jerome F Strauss; Scott W Walsh
Journal:  Am J Pathol       Date:  2010-12-23       Impact factor: 4.307

5.  Neutrophil expression of cyclooxygenase 2 in preeclampsia.

Authors:  Teddi Bachawaty; Sonya L Washington; Scott W Walsh
Journal:  Reprod Sci       Date:  2010-03-10       Impact factor: 3.060

6.  Reduced methylation of the thromboxane synthase gene is correlated with its increased vascular expression in preeclampsia.

Authors:  Ahmad A Mousa; Jerome F Strauss; Scott W Walsh
Journal:  Hypertension       Date:  2012-04-09       Impact factor: 10.190

7.  PAR-2 triggers placenta-derived protease-induced altered VE-cadherin reorganization at endothelial junctions in preeclampsia.

Authors:  Y Gu; L J Groome; J S Alexander; Y Wang
Journal:  Placenta       Date:  2012-07-26       Impact factor: 3.481

Review 8.  Preeclampsia and the future risk of hypertension: the pregnant evidence.

Authors:  Vesna D Garovic; Phyllis August
Journal:  Curr Hypertens Rep       Date:  2013-04       Impact factor: 5.369

9.  Epigenetic Regulation of Interleukin-17-Related Genes and Their Potential Roles in Neutrophil Vascular Infiltration in Preeclampsia.

Authors:  Scott W Walsh; William H Nugent; Kellie J Archer; Marwah Al Dulaimi; Sonya L Washington; Jerome F Strauss
Journal:  Reprod Sci       Date:  2021-05-06       Impact factor: 3.060

Review 10.  The Road to Low-Dose Aspirin Therapy for the Prevention of Preeclampsia Began with the Placenta.

Authors:  Scott W Walsh; Jerome F Strauss
Journal:  Int J Mol Sci       Date:  2021-06-29       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.